Not Tagged
Not Tagged
[]
#cedarssinaicancer at #gi23. dr. ju dong yang is co-author on a prospective clinical trial evaluating the performance of a multi-analyte blood test for early detection of #hepatocellularcarcinoma among at-risk patients with liver #cirrhosis. #gicsm 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.